Page last updated: 2024-08-23

etoposide and Iron Overload

etoposide has been researched along with Iron Overload in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohsaka, H; Komiya, Y; Mizoguchi, F; Saito, T1
Bayrakci, B; Carcillo, JA; Citak, A; Demirkol, D; Dursun, O; Erkek, N; Gedik, H; Karabocuoglu, M; Karapinar, B; Kendirli, T; Kesici, S; Koroglu, TF; Yildizdas, D1

Other Studies

2 other study(ies) available for etoposide and Iron Overload

ArticleYear
Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:23

    Topics: Calcineurin Inhibitors; Dermatomyositis; Drug Therapy, Combination; Etoposide; Female; Glucocorticoids; Heart Failure; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infliximab; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Myocarditis; Prednisolone; Recurrence

2017
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Critical care (London, England), 2012, Dec-12, Volume: 16, Issue:2

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Combined Modality Therapy; Critical Illness; Cyclosporine; Dexamethasone; Etoposide; Female; Ferritins; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Multiple Organ Failure; Plasma Exchange; Prednisolone; Regression Analysis; Sepsis; Survival Rate; Treatment Outcome; Turkey

2012